BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 30069679)

  • 1. The Esophageal Microbiome in Health and Disease.
    Corning B; Copland AP; Frye JW
    Curr Gastroenterol Rep; 2018 Aug; 20(8):39. PubMed ID: 30069679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Snider EJ; Freedberg DE; Abrams JA
    Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The esophageal microbiota in health and disease.
    Di Pilato V; Freschi G; Ringressi MN; Pallecchi L; Rossolini GM; Bechi P
    Ann N Y Acad Sci; 2016 Oct; 1381(1):21-33. PubMed ID: 27415419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.
    Yang L; Lu X; Nossa CW; Francois F; Peek RM; Pei Z
    Gastroenterology; 2009 Aug; 137(2):588-97. PubMed ID: 19394334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cultivable bacterial flora of the esophagus in subjects with esophagitis.
    Norder Grusell E; Dahlén G; Ruth M; Bergquist H; Bove M
    Scand J Gastroenterol; 2018 Jun; 53(6):650-656. PubMed ID: 29616839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
    Yang L; Francois F; Pei Z
    Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature.
    Newberry C; Lynch K
    Curr Gastroenterol Rep; 2017 Aug; 19(8):38. PubMed ID: 28730507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome of the Aerodigestive Tract in Health and Esophageal Disease.
    Hasan A; Hasan LK; Schnabl B; Greytak M; Yadlapati R
    Dig Dis Sci; 2021 Jan; 66(1):12-18. PubMed ID: 33236315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the Esophageal Microbiome and Tissue Gene Expression and Links to the Oral Microbiome: A Randomized Clinical Trial.
    Annavajhala MK; May M; Compres G; Freedberg DE; Graham R; Stump S; Que J; Korem T; Uhlemann AC; Abrams JA
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00235. PubMed ID: 33512805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Esophageal and Gastric Microbiome in Health and Disease.
    Hunt RH; Yaghoobi M
    Gastroenterol Clin North Am; 2017 Mar; 46(1):121-141. PubMed ID: 28164846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
    Sawada A; Fujiwara Y; Nagami Y; Tanaka F; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Gi M; Wanibuchi H; Arakawa T
    Dig Dis Sci; 2016 Nov; 61(11):3161-3168. PubMed ID: 27461059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome, innate immunity, and esophageal adenocarcinoma.
    Baghdadi J; Chaudhary N; Pei Z; Yang L
    Clin Lab Med; 2014 Dec; 34(4):721-32. PubMed ID: 25439272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?
    Blackett KL; Siddhi SS; Cleary S; Steed H; Miller MH; Macfarlane S; Macfarlane GT; Dillon JF
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1084-92. PubMed ID: 23600758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome in reflux disorders and esophageal adenocarcinoma.
    Yang L; Chaudhary N; Baghdadi J; Pei Z
    Cancer J; 2014; 20(3):207-10. PubMed ID: 24855009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal microbiome in eosinophilic esophagitis.
    Harris JK; Fang R; Wagner BD; Choe HN; Kelly CJ; Schroeder S; Moore W; Stevens MJ; Yeckes A; Amsden K; Kagalwalla AF; Zalewski A; Hirano I; Gonsalves N; Henry LN; Masterson JC; Robertson CE; Leung DY; Pace NR; Ackerman SJ; Furuta GT; Fillon SA
    PLoS One; 2015; 10(5):e0128346. PubMed ID: 26020633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
    Neto AG; Whitaker A; Pei Z
    Semin Oncol; 2016 Feb; 43(1):86-96. PubMed ID: 26970127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus and eosinophilic esophagitis].
    Calvet X
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():27-35. PubMed ID: 22330154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.